BCRX vs CHTR · rev $374.7M vs P/E 11, rev $13.53B
BioCryst Pharmaceuticals Inc (BCRX) versus Charter Communications Inc (CHTR) — a side-by-side from cached financials, not a winner call.
BioCryst Pharmaceuticals Inc (BCRX) is a drug manufacturers - specialty & generic company listed on US.
Charter Communications Inc (CHTR) is a telecom services company listed on US.
Latest reported BCRX revenue for 2026-06-30 was $374.7M. Net income was -$643.4M. BCRX currently screens at market cap $1.83B.
Latest reported CHTR revenue for 2026-06-30 was $13.53B. Net income was $1.29B. Revenue was down 0.5% from 2026-03-31 to 2026-06-30. CHTR currently screens at market cap $56.24B and trailing P/E 11.5.
BCRX currently screens at market cap $1.83B. CHTR currently screens at market cap $56.24B and trailing P/E 11.5.
Not investment advice. Open the BCRX and CHTR stock pages for the full models.
Not investment advice.